Sarcoidosis Vasculitis and Diffuse Lung Diseases Sarcoidosis Vasculitis and Diffuse Lung Diseases RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Images in Sarcoidosis: new section of our Journal
Sarcoidosis Vasc Diffuse Lung Dis. 2023 Dec 20;40(4):e2023047. doi: 10.36141/svdld.v40i4.15339.ABSTRACTPMID:38126493 | PMC:PMC10965000 | DOI:10.36141/svdld.v40i4.15339 (Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases)
Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases - December 21, 2023 Category: Respiratory Medicine Authors: Robert P Baughman Antonella Caminati Claudia Ravaglia Luca Richeldi Paola Rottoli Sara Tomassetti Carlo Vancheri Source Type: research

D. Geraint James Lecture: The sarcoidosis saga: what insights from the past will guide us in the future
Sarcoidosis Vasc Diffuse Lung Dis. 2023 Dec 20;40(4):e2023057. doi: 10.36141/svdld.v40i4.15282.ABSTRACTThe sarcoidosis community in general and the World Association of Sarcoidosis and Other Granulomatous diseases (WASOG) in particular have led efforts to improve sarcoidosis diagnosis and care. Evidence based guidelines regarding the diagnosis and treatment have recently been published. In addition, several clinical trials examining existing and new treatments for sarcoidosis have been completed and published. In addition, WASOG has developed criteria and identified Centers of Excellence for sarcoidosis care around the wor...
Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases - December 21, 2023 Category: Respiratory Medicine Authors: Robert P Baughman Elyse Lower Source Type: research

A case of hepatosplenic sarcoidosis accompanied by hypercalcemia
We present a case diagnosed with hepatosplenic sarcoidosis with hypercalcemia. Elevated liver enzymes and hypercalcemia were detected in the patient who was admitted to the hospital with abdominal pain and dyspnea. Abdominal dynamic magnetic resonance imaging (MRI) showed diffuse, multiple, nodular hyperintense lesions on T2 weighted. Multinuclear giant cells and lymphocytic portal inflammation were seen in the patient's liver biopsy, whose angiotensin-converting enzyme level was high, and hepatosplenic sarcoidosis was diagnosed. Shortness of breath, abdominal pain, and calcium level improved with methylprednisolone treatm...
Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases - December 21, 2023 Category: Respiratory Medicine Authors: F üsun Fakılı Nazan G ülhan Bayram Evren Uzun Source Type: research

Could patients' association be considered a strategic resource?
Sarcoidosis Vasc Diffuse Lung Dis. 2023 Dec 20;40(4):e2023046. doi: 10.36141/svdld.v40i4.15221.NO ABSTRACTPMID:38126496 | PMC:PMC10964994 | DOI:10.36141/svdld.v40i4.15221 (Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases)
Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases - December 21, 2023 Category: Respiratory Medicine Authors: Gianluca Ziosi Filippo Martone Source Type: research

Choroidal Nodules in Ocular Sarcoidosis
CONCLUSIONS: Knowledge of this presentation of ocular sarcoidosis can help clinicians optimize treatment outcomes for patients.PMID:38126497 | PMC:PMC10965004 | DOI:10.36141/svdld.v40i4.15122 (Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases)
Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases - December 21, 2023 Category: Respiratory Medicine Authors: St éphane Abramowicz Michel Wassef Sara Touhami Source Type: research

Radiological predictive remission factors of pulmonary involvement in systemic sarcoidosis: a computed tomography scan study
CONCLUSION: In patients with systemic sarcoidosis with no lymphopenia at onset or calcifications or typical CT scan findings at presentation, we suggest a close follow-up as well as an intensive treatment.PMID:38126498 | PMC:PMC10965001 | DOI:10.36141/svdld.v40i4.15118 (Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases)
Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases - December 21, 2023 Category: Respiratory Medicine Authors: Melek Kechida Mabrouk Abdelali Rym Mesfar Imene Chaabene Rim Klii Sonia Hammami Syrine Daadaa Mezri Maatouk Jamel Saad Ahmed Zrig Ines Khochtali Source Type: research

Incidence, clinical features, management and outcomes of ANCA-associated vasculitis in pregnancy- a systematic literature review
Conclusions: Patients can have positive maternal and foetal outcomes following strong induction therapy, vigorous monitoring and prompt treatment of flares during pregnancy. Serious complications and flares are not associated with worse outcomes for newborns.PMID:38126499 | PMC:PMC10965006 | DOI:10.36141/svdld.v40i4.15094 (Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases)
Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases - December 21, 2023 Category: Respiratory Medicine Authors: Apurva Ashok Laura Russell Mrinalini Dey Koushan Kouranloo Source Type: research

The clinical, functional, and radiological effect of long-term used immunosuppressive therapy for post-COVID-19 interstitial lung disease
CONCLUSIONS: Long-term immunosuppressive therapy may be preferred in proper cases of post-COVID-19-ILD as an effective and safe treatment option that improves the quality of life, respiratory parameters, and radiologic findings.PMID:38126500 | PMC:PMC10965009 | DOI:10.36141/svdld.v40i4.15055 (Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases)
Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases - December 21, 2023 Category: Respiratory Medicine Authors: Sule Gul Bar ış Demirkol Ramazan Eren Kursad Nuri Baydili Burcu Babao ğlu Elkhatroushi Şerife Nur Ulusan Umut İlhan Mustafa Çörtük Erdo ğan Çetinkaya Source Type: research

Recurrent spontaneous pneumothorax under nintedanib treatment in ınterstitial lung disease associated with systemic sclerosis
Sarcoidosis Vasc Diffuse Lung Dis. 2023 Dec 20;40(4):e2023044. doi: 10.36141/svdld.v40i4.14716.ABSTRACTInterstitial lung disease (ILD) is a common complication that can develop during the course of systemic sclerosis (SSc). Nindetanib is an antifibrotic drug approved for the treatment of systemic sclerosis-associated interstitial lung disease. Although there is an insufficient data on the development of pneumothorax, the safety of Nintedanib treatment is also uncertain. We observed recurrent resistant pneumothorax under nintedanib treatment in a patient with systemic sclerosis-associated interstitial lung disease. Nintedan...
Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases - December 21, 2023 Category: Respiratory Medicine Authors: Abdurrahman Soner Şenel Tu ğba Kahraman Denizhan Melih K ızıltepe Emel O ğuz Kökoğlu Nuri Tutar Source Type: research

Meta-analysis: clinical features and treatments of lung cancer in combined pulmonary fibrosis and emphysema
CONCLUSIONS: Lung cancer in CPFE, most commonly SQCC, presents in elderly heavy smokers with a male, located in the lower lobe of the lung and the areas of fibrosis predominance. Chemotherapy is the main treatment and the optimal treatment remains to be explored.PMID:38126502 | PMC:PMC10965002 | DOI:10.36141/svdld.v40i4.14433 (Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases)
Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases - December 21, 2023 Category: Respiratory Medicine Authors: Jiayu Zhou Yu Jiang Source Type: research

Quadruple overlapping autoimmune diseases manifested as sarcoidosis with mediastinal lymphadenopathy: a case report
We present a rare case of a 55-year-old female patient with quadruple overlapping autoimmune diseases, including vitiligo, autoimmune hypothyroidism, ulcerative colitis, and sarcoidosis with mediastinal lymphadenopathy. The patient had been suffering from vitiligo since 2003 and was diagnosed with autoimmune hypothyroidism and ulcerative colitis through thyroid ultrasound and colonoscopy, respectively. After physical examination, mediastinal lymph nodes enlargement was detected, and sarcoidosis was diagnosed through ultrasound bronchoscope-guided transbronchial needle aspiration (EBUS-TBNA), which is a quadruple overlappin...
Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases - December 21, 2023 Category: Respiratory Medicine Authors: Mengjie Li Huan Wang Cuiping Li Linming Su Jian Zhu Source Type: research

Can TERT rs2853669 polymorphysm indicate fibrosis in sarcoidosis?
CONCLUSIONS: In sarcoidosis patients, telomerase rs2853669 polymorphism does not indicate progression to fibrosis, but since FEV1% was found to be lower in individuals with homozygous CC polymorphism, it is thought that it may predict loss of respiratory function. Further studies are needed to evaluate the association of telomerase polymorphisms with fibrosis in sarcoidosis.PMID:38126504 | PMC:PMC10965005 | DOI:10.36141/svdld.v40i4.14023 (Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases)
Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases - December 21, 2023 Category: Respiratory Medicine Authors: S ümeyye Kement Eda Turgut Ugurtay Asl ı Tanrıvermis Sayıt P ınar Tascı Meftun Unsal Source Type: research

An unusual case of sarcoidosis presenting as calf pain
Sarcoidosis Vasc Diffuse Lung Dis. 2023 Dec 20;40(4):e2023056. doi: 10.36141/svdld.v40i4.14004.ABSTRACTSarcoidosis is a multisystem chronic inflammatory disease predominantly affecting the lungs. Myositis as a presenting manifestation of sarcoidosis is extremely uncommon and seldom reported. Here we report a 20-year-old male who presented with bilateral calf pain for six months. On evaluation magnetic resonance imaging showed features of myositis, and muscle biopsy was suggestive of sarcoidosis with granulomatous vasculitis. Positron emission tomography-computed tomography scan revealed involvement of spleen in addition to...
Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases - December 21, 2023 Category: Respiratory Medicine Authors: Nayan Patel Sureja Meenakshi Swain Santhi Bhushan Murari Power Ravuri Source Type: research

Long term nitrofurantoin induced interstitial lung disease: a case series and literature review
CONCLUSIONS: Cautious counselling should be undertaken prior to nitrofurantoin prescription regardless of renal function.PMID:38126506 | PMC:PMC10964995 | DOI:10.36141/svdld.v40i4.13827 (Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases)
Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases - December 21, 2023 Category: Respiratory Medicine Authors: Samiha Naureen Simon Hart Nadia Jawad Nuala Kennan Shoaib Faruqi Source Type: research

Outcomes in patients with sarcoidosis and COVID-19
CONCLUSIONS: Patients with sarcoidosis may not be at increased risk of critical illness or death from COVID-19, and immunosuppression therapy in these patients may reduce the risk of critical COVID-19.PMID:38126507 | PMC:PMC10965003 | DOI:10.36141/svdld.v40i4.13855 (Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases)
Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases - December 21, 2023 Category: Respiratory Medicine Authors: Owais Nadeem Amreeta Sharma Diana Alaouie Patrick Bradley Dan Ouellette Raef Fadel Geehan Suleyman Source Type: research